A Career Is Finished Before It Starts

Science is like a professional sport. Both are played by young people and managed by older people no longer capable of playing. In sport the inability of older people to play is so obvious that they do not expect or try to do so. Someone entering pro sports knows that his or her high-paying career will be short. A few will stay on as managers or lower-status, non-playing auxiliaries, but most will leave the sport entirely. Scientists are now being involuntarily retired at about the same age as

Written byCharles Mccutchen
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Science is like a professional sport. Both are played by young people and managed by older people no longer capable of playing. In sport the inability of older people to play is so obvious that they do not expect or try to do so. Someone entering pro sports knows that his or her high-paying career will be short. A few will stay on as managers or lower-status, non-playing auxiliaries, but most will leave the sport entirely.

Scientists are now being involuntarily retired at about the same age as athletes, which is about the age when the fall in their creative powers gets serious. Their departure is little if any loss to science, but they entered science with the expectation of lifetime careers and feel betrayed. The generation before them had lifetime careers; why shouldn't they?

They were told, or allowed to believe, a lie, that grad student and postdoc years ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies